AFG
CRL icon

Atomi Financial Group’s Charles River Laboratories CRL Stock Holding History

Atomi Financial Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$324K Sell
1,431
-179
-11% -$31.9K 0.01% 992
2026
Q1 		$278K Sell
1,610
-58
-3% -$10.8K 0.01% 995
2025
Q4 		$333K Buy
1,668
+273
+20% +$49.5K 0.01% 884
2025
Q3 		$218K Buy
+1,395
New +$222K 0.01% 1078
2025
Q2 		– Sell
-1,879
Closed -$283K – 1123
2025
Q1 		$283K Buy
1,879
+265
+16% +$44.4K 0.01% 800
2024
Q4 		$298K Sell
1,614
-218
-12% -$42K 0.02% 725
2024
Q3 		$361K Sell
1,832
-82
-4% -$17K 0.02% 592
2024
Q2 		$395K Sell
1,914
-82
-4% -$18.6K 0.03% 465
2024
Q1 		$541K Buy
+1,996
New +$477K 0.05% 325

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Atomi Financial Group's CRL Position: Q2 2026 in Review

Atomi Financial Group reduced its Charles River Laboratories (CRL) stake by 11% in Q2 2026, selling an estimated $31.9K and leaving 1,431 shares worth $324K. The position accounts for 0.01% of the portfolio, ranked #992.

Atomi Financial Group first reported a position in CRL in Q1 2024 and has held it in 9 quarters since. The position peaked at $541K in Q1 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Atomi Financial Group held 1,431 shares of Charles River Laboratories worth $324K as of Q2 2026.
  • Atomi Financial Group sold 179 Charles River Laboratories shares in Q2 2026, an estimated $31.9K.
  • Charles River Laboratories made up 0.01% of Atomi Financial Group's portfolio in Q2 2026, its #992 holding.
  • Atomi Financial Group first reported a position in Charles River Laboratories in Q1 2024 and has held it in 9 quarters since.
  • Atomi Financial Group's Charles River Laboratories position peaked at $541K in Q1 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.